Old Web
English
Sign In
Acemap
>
Paper
>
Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy.
Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy.
1988
Layton Dm
Ghulam J. Mufti
J. Lyons
J. W. G. Janssen
Bartram Cr
Keywords:
Cancer research
Cytarabine
Medicine
Mutation
Oncogene
low dose cytarabine
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
37
Citations
NaN
KQI
[]